During the IFSO14, 19th World Congress held in Montreal in 2014, where nearly 2000 registrants gathered to discuss current topics of obesity surgery and related techniques, an Ba propos^symposium was held in collegiality entitled BManagement of Barrett's in patients having Bariatric Surgery.^Barrett's disease in the bariatric surgery patient or the patient considering bariatric surgery has always been a topic of interest and one with limited published information. As sleeve gastrectomy continues to rise in popularity and is now likely to be the most preferred operation worldwide, Barrett's has become an extremely important topic. The symposium effectively explored this issue from several angles.
Five papers are being published from this symposium here, with various opinions and views. The highlighted topics include the prevalence of Barrett's in patients having weight loss surgery (sleeve gastrectomy), controversies regarding sleeve gastrectomy being performed in patients with GERD and Barrett's, the utility of Rouxen-Y gastric bypass for morbidly obese patients with GERD, current endoluminal therapies for Barrett's esophagus (that could be used pre-or postoperatively), and finally, considerations regarding the traditional surgical treatment of Barrett's esophagus with dysplasia in patients with prior sleeve gastrectomy or Roux-en-Y gastric bypass.
We thank the editor-in-chief, Dr Scott Shikora, for his guidance and support in putting this together for the first time in Obesity Surgery, and we hope the readers will find it suitable and discover new options for their daily practice.
